The current SOLV market cap is 11.55B. The company's latest EPS is USD 4.0057 and P/E is 16.68.
Quarter End | Mar 2024 |
---|---|
USD ($) | |
Total Revenue | 2.02B |
Operating Income | 381M |
Net Income | 237M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 8.24B |
Operating Income | 1.48B |
Net Income | 692M |
Quarter End | Mar 2024 |
---|---|
USD ($) | |
Total Assets | 14.71B |
Total Liabilities | 10.86B |
Total Equity | 3.85B |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 14.38B |
Total Liabilities | 10.97B |
Total Equity | 3.41B |
Market Cap | 11.55B |
Price to Earnings Ratio | 16.68 |
Price to Sales Ratio | 1.4 |
Price to Cash Ratio | 19.23 |
Price to Book Ratio | 3.39 |
Dividend Yield | - |
Shares Outstanding | 172.75M |
Average Volume (1 week) | 767.74k |
Average Volume (1 Month) | 821.59k |
52 Week Change | -3.36% |
52 Week High | 76.4306 |
52 Week Low | 47.16 |
Spread (Intraday) | 0.45 (0.67%) |
Company Name | Solventum Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.solventum.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.